Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 2, 2006, Pages

  Yoshida, Mizuko ^a   Yonetani, Akira ^b   Shirasaki, Toshihiro ^b   Wada, Keiji ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b HITACHI HIGH TECHNOLOGIES CORPORATION   (Japan)

Author keywords

Blood; Calcium and zinc; Potassium; Serum creatine kinase activity; Therapy

Indexed keywords

CALCIUM ION; CREATINE KINASE; MAGNESIUM ION; SODIUM CHLORIDE; SODIUM ION; ZINC ION; CALCIUM; POTASSIUM; SODIUM; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIET SUPPLEMENTATION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; FEMALE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; SALT INTAKE; SEX DIFFERENCE; SODIUM BLOOD LEVEL; TIBIALIS ANTERIOR MUSCLE; AGING; ANIMAL; BLOOD; DIET THERAPY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; METABOLISM; NECROSIS; PATHOLOGY; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

AGING; ANIMALS; CALCIUM; CREATINE KINASE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; FEMALE; MALE; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NECROSIS; POTASSIUM; SODIUM; SODIUM CHLORIDE; ZINC;

EID: 33644859605     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00684.2004     Document Type: Article

References (49)

1. 2+ exchange in intact single skeletal muscle fibers from the mouse. Am J Physiol Cell Physiol 274: C940-C946, 1998.
2. Beam KG. Duchenne muscular dystrophy. Localizing the gene product. Nature 333: 798-799, 1988.
3. Bertorini TE, Bhattacharya SK, Palmieri GM, Chesney CM, Pifer D, and Baker B. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32: 1088-1092, 1982.
4. Bertorini TE, Cornelio F, Bhattacharya SK, Palmieri GM, Dones I, Dworzak F, Brambati B, Chesney CM, Pifer D, and Baker B. Calcium and magnesium content in fetuses at risk and prenecrotic Duchenne muscular dystrophy. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 34: 1436-1440, 1984.
5. Bettger WJ and O'Dell BL. Physiological roles of zinc in the plasma membrane of mammalian cells. J Nutr Biochem 4: 194-207, 1993.
6. Bodensteiner JB and Engel AG. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28: 439-446, 1978.
7. Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, and Smith J. Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69: 1017-1025, 1982.
8. Buetler TM, Renard M, Offord EA, Schneider H, and Ruegg UT. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 75: 749-753, 2002.
9. Bukoski RD, Xue H, and McCarron DA. Effect of 1,25(OH)2 vitamin D3 and ionized Ca2+ on 45Ca uptake by primary cultures of aortic myocytes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. Biochem Biophys Res Commun 146: 1330-1335, 1987.
10. Campbell KP and Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259-262, 1989.
11. Carpenter S and Karpati G. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102: 147-161, 1979.
12. Collet C, Csernoch L, and Jacquemond V. Intramembrane charge movement and L-type calcium current in skeletal muscle fibers isolated from control and mdx mice. Biophys J 84: 251-265, 2003.
13. Deval E, Levitsky DO, Marchand E, Cantereau A, Raymond G, and Cognard C. Na(+)/Ca(2+) exchange in human myotubes: intracellular calcium rises in response to external sodium depletion are enhanced in DMD. Neuromuscul Disord 12: 665-673, 2002.
14. Dhalla NS, McNamara DB, Balasubramanian V, Greenlaw R, and Tucker FR. Alterations of adenosine triphosphatase activities in dystrophic muscle sarcolemma. Res Commun Chem Pathol Pharmacol 6: 643-650, 1973.
15. Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscul Disord 1: 19-29, 1991.
16. Engel AG, Yamamoto M, and Fischbeck KH. Dystrophinopathies. In: Myology (2nd ed.), edited by Engel AG and Franzini-Armstrong, C. New York: McGraw-Hill, 1133-1187, 1994.
17. Fisher I, Abraham D, Bouri K, Hoffman EP, Muntoni F, and Morgan J. Prednisolone-induced changes in dystrophic skeletal muscle. FASEB J 19: 834-836, 2005.
18. Fong PY, Turner PR, Denetclaw WF, and Steinhardt RA. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250: 673-676, 1990.
19. Glesby MJ, Rosenmann E, Nylen EG, and Wrogemann K. Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy. Muscle Nerve 11: 852-856, 1988.
20. Gorospe JRM, Nishikawa BK, and Hoffman EP. Pathophysiology of dystrophin deficiency: a clinical and biological enigma. In: Dystrophin Gene, Protein and Cell Biology, edited by Brown SC and Lucy JA: New York: Cambridge University Press, pp. 201-232, 1997.
21. Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, and Danos O. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping. Science 306: 1796-1799, 2004.
22. Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, and Chamberlain JS. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8: 253-261, 2002.
23. Hubner C, Lehr HA, Bodlaj R, Finckh B, Oexle K, Marklund SL, Freudenberg K, Kontush A, Speer A, Terwolbeck K, Voit T, and Kohlschutter A. Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy. Pediatr Res 40: 444-449, 1996.
24. Jackson MJ, Jones DA, and Edwards RH. Measurements of calcium and other elements in muscle biopsy samples from patients with Duchenne muscular dystrophy. Clin Chim Acta 147: 215-221, 1985.
25. 2+ release. Am J Physiol Regul Integr Comp Physiol 287: R1101-R1109, 2004.
26. Lijnen P and Petrov V. Dietary calcium, blood pressure and cell membrane cation transport systems in males. J Hypertens 13: 875-882, 1995.
27. Luttgau HC. The action of calcium ions on potassium contractures of single muscle fibres. J Physiol 168: 679-697, 1963.
28. Marchi Alves LM, Tosi LR, Antunes-Rodrigues J, and Carnio EC. Is there a link between salt-intake and atrial natriuretic peptide system during hypertension induced by nitric oxide blockade? Regul Pept 120: 127-132, 2004.
29. Maunder-Sewry CA, Gorodetsky R, Yarom R, and Dubowitz V. Element analysis of skeletal muscle in Duchenne muscular dystrophy using x-ray fluorescence spectrometry. Muscle Nerve 3: 502-508, 1980.
30. McArdle A, Edwards RH, and Jackson MJ. Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro. Clin Sci (Lond) 82: 455-459, 1992.
31. National Research Council. Nutrient requirements of the mouse. In: Nutrient Requirements of Laboratory Animals, Washington, D.C.: National Academy Press, chapt. 3, p. 80, 1995.
32. Okinaka S, Kumagai H, Ebashi S, Sugita H, Momoi H, Toyokura Y, and Fujie Y. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol 4: 520-525, 1961.
33. Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, Wallimann T, and Ruegg UT. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 12: 174-182, 2002.
34. Reeve JL, McArdle A, and Jackson MJ. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice. Muscle Nerve 20: 357-360, 1997.
35. Reineck HJ, Osgood RW, Ferris TF, and Stein JH. Potassium transport in the distal tubule and collecting duct of the rat. Am J Physiol 229: 1403-1409, 1975.
36. Shiramine K, Aou S, and Hori T. Lateral hypothalamic injection of GABA(A) antagonist induces gastric vagus-mediated hypocalcemia in the rat. Am J Physiol Regul Integr Comp Physiol 273: R1492-R1500, 1997.
37. Spencer MJ and Mellgren RL. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 11: 2645-2655, 2002.
38. Suh JG, Yamazaki A, and Tomita T. Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers. Lab Anim Sci 44: 42-46, 1994.
39. Sulakhe PV, Fedelesova M, McNamara DB, and Dhalla NS. Isolation of skeletal muscle membrane fragments containing active Na+-K+ stimulated ATPase: comparison of normal and dystrophic muscle sarcolemma. Biochem Biophys Res Commun 42: 793-800, 1971.
40. Takagi A, Watanabe T, Kojima S, and Endo Y. Effect of long-term administration of prednisolone on serum creatine kinase and muscle pathology of mdx mouse. Rinsho Shinkeigaku 38: 724-728, 1998.
41. Tameyasu T, Yamada M, Tanaka M, and Takahashi S. Effect of zinc-carnosine chelate compound on muscle function in mdx mouse. Jpn J Physiol 52: 111-120, 2002.
42. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, and Davies KE. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384: 349-353, 1996.
43. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J, Chen C, Li J, and Xiao X. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23: 321-328, 2005.
44. Watkins SC, Hoffman EP, Slayter HS, and Kunkel LM. Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333: 863-866, 1988.
45. Winegar BD and Lansman JB. Voltage-dependent block by zinc of single calcium channels in mouse myotubes. J Physiol 425: 563-578, 1990.
46. Yilmaz O, Karaduman A, and Topaloglu H. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 11: 541-544, 2004.
47. Yoshida M, Matsuzaki T, Date M, and Wada K. Skeletal muscle fiber degeneration in mdx mice induced by electrical stimulation. Muscle Nerve 20: 1422-1432, 1997.
48. Zatz M, Shapiro LJ, Campion DS, Oda E, and Kaback MM. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies. J Neurol Sci 36: 349-362, 1978.
49. Zemel MB, Bedford BA, Zemel PC, Marwah O, and Sowers JR. Altered cation transport in non-insulin-dependent diabetic hypertension: effects of dietary calcium. J Hypertens Suppl 6: S228-S230, 1988.